BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11706095)

  • 1. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
    Buckley C; Newsom-Davis J; Willcox N; Vincent A
    Neurology; 2001 Nov; 57(9):1579-82. PubMed ID: 11706095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
    Shelton GD; Skeie GO; Kass PH; Aarli JA
    Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
    Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
    Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occurrence of anti-titin antibodies and thymomas: a population survey of MG 1970-1999.
    Somnier FE; Engel PJ
    Neurology; 2002 Jul; 59(1):92-8. PubMed ID: 12105313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-titin antibodies are not associated with a specific thymoma histology.
    Voltz R; Albrich W; Hohlfeld R; Nagel D; Wick M; Kirchner T; Sommer N; Illa I; Kaminski H; Schumm F
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):282. PubMed ID: 12531976
    [No Abstract]   [Full Text] [Related]  

  • 7. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
    Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
    J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients.
    Yamamoto AM; Gajdos P; Eymard B; Tranchant C; Warter JM; Gomez L; Bourquin C; Bach JF; Garchon HJ
    Arch Neurol; 2001 Jun; 58(6):885-90. PubMed ID: 11405802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
    Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
    Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
    Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes.
    Skeie GO; Pandey JP; Aarli JA; Gilhus NE
    Autoimmunity; 1997; 26(2):111-6. PubMed ID: 9546812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
    Chen XJ; Qiao J; Xiao BG; Lu CZ
    J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
    Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
    Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle autoantibodies in subgroups of myasthenia gravis patients.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes.
    Lübke E; Freiburg A; Skeie GO; Kolmerer B; Labeit S; Aarli JA; Gilhus NE; Wollmann R; Wussling M; Rüegg JC; Linke WA
    J Neuroimmunol; 1998 Jan; 81(1-2):98-108. PubMed ID: 9521611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Titin, thymoma, and myasthenia gravis.
    Aarli JA
    Arch Neurol; 2001 Jun; 58(6):869-70. PubMed ID: 11405799
    [No Abstract]   [Full Text] [Related]  

  • 17. Myasthenia gravis in individuals over 40.
    Aarli JA; Romi F; Skeie GO; Gilhus NE
    Ann N Y Acad Sci; 2003 Sep; 998():424-31. PubMed ID: 14592910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin.
    Aarli JA; Stefansson K; Marton LS; Wollmann RL
    Clin Exp Immunol; 1990 Nov; 82(2):284-8. PubMed ID: 2242609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations.
    Skeie GO; Mygland A; Aarli JA; Gilhus NE
    Autoimmunity; 1995; 20(2):99-104. PubMed ID: 7578874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum anti-titin antibody in patients with myasthenia gravis].
    Li YF; Zhang JB; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.